Branebrutinib acid

SL-10188

Branebrutinib acid, >98%

IUPAC Name : (S)-4-(3-(But-2-ynamido)piperidin-1-yl)-5-fluoro-2,3-dimethyl-1H-indole-7-carboxylic acid

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
10MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
25MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
50MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
100MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026

Applications : This is an impurity of Branebrutinib, which is a potent, covalent, irreversible inhibitor of bruton’s tyrosine kinase (BTK). Branebrutinib is currently being evaluated in clinical trials for various autoimmune inflammatory disorders, including rheumatoid arthritis, systemic lupus erythematosus, primary Sjögren's syndrome, and atopic dermatitis.

References : Watterson H. S. et al.: J. Med. Chem., 62(7), 3228−3250, 2019.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.